Enantioselective Pd-Catalyzed Reactions Enabled by Imidazole-based Chiral Biaryl Ligands
Enantioselective Pd-Catalyzed Reactions Enabled by Imidazole-based Chiral Biaryl Ligands
批准号:
2154071
负责人:
Aaron Aponick
金额:
$52.5万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-01 至 2025-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
With support of the Chemical Synthesis program in the Division of Chemistry, Professor Aaron Aponick of the University of Florida will study new palladium-catalyzed reactions designed to improve the manufacture of chemical compounds used in agriculture, clean energy technologies, and human health. A prominent feature of the research is that it will enable the generation of products in a so-called 'optically active form' in which one 'enantiomeric configuration' (approximately equivalent to the concept of handedness) of the molecule predominates. The broader impacts of the project will extend to providing hands-on training for students, preparing them for the modern workforce. In addition, public outreach in science, technology, engineering, and mathematics (STEM) will be achieved through an educational event called "Chemistry Day at the Mall, Molecular Mania." This event is popular with children and fosters interactions with the public, in general. Many visitors with diverse socioeconomic backgrounds participate.Palladium-catalyzed reactions of olefins have long been recognized as excellent starting points for the preparation of feedstock and fine chemicals. Many such transformations involve a nucleopalladation reaction; however, subtle changes in reaction parameters impact reaction mechanism making it difficult to design reliable enantioselective processes. The funded project specifically addresses challenges in carbofunctionalization by the utilization of Pd(II)•StackPhos complexes in enantioselective endo-1,2-alkene difunctionalization reactions. Herein, the catalyst controls the stereochemical configuration of products by recognizing a specific olefin pi-face, leading to net enantioselective olefin functionalization reactions. A key goal of the research is to identify catalysts that exhibit high levels of stereoselectivity for both syn- and anti-addition reactions. Mechanistic probes will be used to glean information in regard to the mode of addition. Further studies are aimed at carbocycle-forming reactions, primarily through the endo-mode cyclization and complementing the more highly developed exo-mode cyclizations currently available. Additional work will expand on the kinds of transformations hitherto investigated to encompass alternative substrates that may also lead to useful enantioenriched products. Successful realization of the goals of the funded project will have a significant impact on the field of transition metal-mediated catalysis by providing a fundamental understanding of the factors necessary for enantioselective endo-1,2-difunctionalization reactions. It is anticipated that the findings will enable widespread deployment of this strategy across a range of synthetic applications in both academic and industrial laboratories.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enantioselective Catalysis Enabled by Imidazole-Based Biaryl Ligands
-
批准号:1900299
-
项目类别:Standard Grant
-
资助金额:$45.0万
-
财政年份:2019
-
负责人:Aaron Aponick
-
依托单位:
Chiral Biaryl Heterocycles as Ligands for Enantioselective Catalysis
-
批准号:1362498
-
项目类别:Standard Grant
-
资助金额:$42.0万
-
财政年份:2014
-
负责人:Aaron Aponick
-
依托单位:
Self-Assembled Catalysts for Asymmetric Ring Opening Reactions
-
批准号:0957643
-
项目类别:Continuing Grant
-
资助金额:$38.0万
-
财政年份:2010
-
负责人:Aaron Aponick
-
依托单位:
国内基金
海外基金
登录
查看更多内容
千金藤素调控TSPO及RILP加速自噬降解PD-L1增强肺癌免疫治疗的作用及机制
-
批准号:JCZRLH202600242
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
LncRNA HNRNPA1P21通过诱导M2极化和PD-L1表达促进肺癌进展的机制研究
-
批准号:JCZRLH202601430
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于PD-L1/PD-1通路探讨标本配穴电针调控Th17/Treg平衡改善肥胖胰岛素抵抗的作用机制
-
批准号:JCZRLH202600504
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
OSMI-4靶向O-糖基化调控PD-L1联合裂解OK-432协同治疗不完全消融后残存肝癌的机制研究
-
批准号:JCZRLH202600261
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
孕激素调控肿瘤微环境细胞因子网络重塑卵巢癌免疫景观并提升PD-L1抑制剂疗效的机制研究
-
批准号:2026JJ80980
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王志斌
-
依托单位:
靶向Gal-1提高肝内胆管癌T细胞功能及增敏PD-1免疫治疗的机制研究
-
批准号:2026JJ81642
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李浩
-
依托单位:
UDCA抑制G6PD活性诱导 HCC 细胞铁死亡的抗肝癌机制研究
-
批准号:2026JJ82280
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:熊玉婕
-
依托单位:
Wnt通路介导PD-1调控巨噬细胞极化对高脂血症性急性胰腺炎的影响及机制研究
-
批准号:2026JJ82356
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李想
-
依托单位:
糖脂代谢重塑型金属多酚纳米药物促进CD8+ T细胞活化浸润增效PD-1抗体治疗三阴性乳腺癌的研究
-
批准号:2026JJ50635
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘芙蓉
-
依托单位:
基于PD-L1 靶向的金-钆纳米粒在晚期三阴性乳腺癌免疫微环境可视化与协同治疗的应用研究
-
批准号:JCZRLH202601281
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: